Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Hemostemix Inc HMTXF


Primary Symbol: V.HEM

Healthcare Biotechnology
Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:HEM)

Hemostemix Announces the First Tranche Closing of $1.8M of Its Recently Announced Private Placement

Newsfile October 31, 2024

Hemostemix's Private Placement

Newsfile October 11, 2024

Canadian Investment Regulatory Organization Trade Resumption - HEM

Canada NewsWire August 2, 2024

Hemostemix Closes its Funded Manufacturing Services Agreement with CytoImmune, Restarting Production of ACP-01

Newsfile August 1, 2024

Canadian Investment Regulatory Organization Trading Halt - HEM

Canada NewsWire August 1, 2024

Hemostemix Announces Trademark Granted by Switzerland and Interest Payment

Newsfile June 11, 2024

Hemostemix Announces Strategic Manufacturing Partnership with CytoImmune Therapeutics and $1,800,000 in Financing Commitments

Newsfile June 3, 2024

Hemostemix Announces Engagement of Oak Hill Asset Management Inc.

Newsfile March 7, 2024

Hemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental Sciences

Newsfile February 6, 2024
View More News ››

Opinion & Analysis (TSXV:HEM)

Shaping the Future of Regenerative Medicine Today

Dave Jackson February 11, 2021

Hemostemix Founder: A Man with a Compassionate Heart

Featured Submission December 15, 2020

Shaping the Future of Medicine by Delivering Regenerative Medicines

Dave Jackson December 9, 2020
View More Opinion ››

Bullboard Posts (TSXV:HEM)

Hemostemix led last week’s top performers with a 50% gain

Hemostemix led last week’s top performers with a 50% gain. As highlighted last week, HEM is actively pursuing a $4M equity financing...
cmarketinsights - October 22, 2024

Hemostemix is pursuing a $4M equity financing

Hemostemix is pursuing a $4M equity financing to further develop its ACP-01 product, which targets patients with critical limb ischemia...
cmarketinsights - October 16, 2024

Cytolmmune

Not Hemostemix wesite. Im talking about Cytolmmunes website.
valiantaffair - October 14, 2024

RE:Cytolmmune

There are 6 Press Releases during 2024 posted to their website:   https://hemostemix.com/news-press-releases/
cndinvest - October 12, 2024

Cytolmmune

Their website has not been updated since 2023. I think this company is done. No deal for Hemostemix. Whats next Tom back to Quebec huh...
valiantaffair - October 9, 2024

Hemostemix went up 22% wow as of july 15

Hemostemix went up 22% wow as of july 15. Can this be linked to their recent announcement relating to trademark granted by Switzerland...
sdhaka - July 16, 2024
View more Bullboard ››

Southern Silver Exploration Corp.

Southern Silver Exploration Corp.

Southern Silver Exploration Corp is a Canadian company engaged in the acquisition, exploration, and development of natural ...
View More »